November 16, 1978New England Journal of Medicine
Intrapericardial Tetracycline for the Management of Cardiac Tamponade Secondary to Malignant Pericardial Effusion
Why the study?
Does intrapericardial tetracycline improve outcomes in patients with cardiac tamponade secondary to malignant pericardial effusion?
Population
Patients with cardiac tamponade secondary to malignant pericardial effusion
Design
Other
Authors
Discussion
Loading...
Member takes
Implication
May not yet support routine use in malignant tamponade; leaves open its role as alternative pending controlled trials.
Structured PICO
Does intrapericardial tetracycline improve outcomes in patients with cardiac tamponade secondary to malignant pericardial effusion?
P
Population
Patients with cardiac tamponade secondary to malignant pericardial effusion
I
Intervention
Intrapericardial tetracycline
Intrapericardial tetracycline is introduced as a potential alternative to traditional chemotherapeutic agents for managing malignant pericardial effusion with cardiac tamponade.
Cite This Study
Davis et al. (1978) studied this question.